Stock-Based Compensation Plans (Tables)
|
12 Months Ended |
Dec. 31, 2014
|
Summary of Stock Option Activity - Pre-IPO |
The following is a summary of MMREIS’s stock option
activity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
December 31, |
|
|
|
2013 |
|
|
2012 |
|
|
|
Shares
Under
Options |
|
|
Weighted-
Average
Exercise
Price |
|
|
Shares
Under
Options |
|
|
Weighted-
Average
Exercise
Price |
|
Options outstanding at beginning of year:
|
|
|
750 |
|
|
$ |
28.86 |
|
|
|
3,500 |
|
|
$ |
25.67 |
|
Granted
|
|
|
— |
|
|
|
— |
|
|
|
750 |
|
|
|
28.86 |
|
Exercised
|
|
|
(750 |
) |
|
|
28.86 |
|
|
|
(3,500 |
) |
|
|
25.67 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options outstanding at end of year
|
|
|
— |
|
|
$ |
— |
|
|
|
750 |
|
|
$ |
28.86 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Summary of Restricted Common Stock Activity - Pre - IPO |
The following is a summary of MMREIS’s restricted common
stock activity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2013 |
|
|
2012 |
|
|
|
Restricted
Stock |
|
|
Weighted-
Average
Grant
Date Fair
Value |
|
|
Restricted
Stock |
|
|
Weighted-
Average
Grant
Date Fair
Value |
|
Restricted common stock outstanding at beginning of year:
|
|
|
27,999 |
|
|
$ |
23.67 |
|
|
|
24,499 |
|
|
$ |
23.36 |
|
Issued upon exercise of stock options
|
|
|
750 |
|
|
|
28.86 |
|
|
|
3,500 |
|
|
|
25.87 |
|
Exchange of common stock (1)
|
|
|
(28,749 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted common stock outstanding at end of year
|
|
|
— |
|
|
$ |
— |
|
|
|
27,999 |
|
|
$ |
23.67 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted common stock vested at end of year
|
|
|
— |
|
|
|
|
|
|
|
22,682 |
|
|
|
|
|
Restricted common stock unvested at end of year
|
|
|
— |
|
|
|
|
|
|
|
5,317 |
|
|
|
|
|
(1) |
Exchanged for new Marcus &
Millichap stock prior to the IPO. Refer to Note 9 –
“Stockholders’ Equity” for additional information
on the exchange of common stock. |
|
Summary of SARs Activity - Pre - IPO |
The following is a summary of MMREIS’s SARs activity:
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2013
|
|
|
2012
|
|
SARs outstanding at beginning of period:
|
|
|
28,733 |
|
|
|
27,983 |
|
Granted
|
|
|
— |
|
|
|
750 |
|
Settled (1)
|
|
|
(28,733 |
) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
SARs outstanding at end of period
|
|
|
— |
|
|
|
28,733 |
|
|
|
|
|
|
|
|
|
|
SARs vested at end of period
|
|
|
— |
|
|
|
22,666 |
|
|
|
|
|
|
|
|
|
|
(1) |
Prior to the IPO, outstanding
SAR’s were settled by exchanging the SAR’s for
DSU’s for 2,192,413 shares of the new Marcus &
Millichap common stock and a fixed SAR’s liability amount.
SeeAmendments to Restricted Stock and SARs below. |
|
Components of Stock-Based Compensation Included in Consolidated Statements of Net and Comprehensive Income |
The following table summarizes the components of stock-based
compensation included in the consolidated statements of net and
comprehensive income (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
December 31, |
|
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
Restricted stock and SARs (prior to IPO)
|
|
$ |
— |
|
|
$ |
4,679 |
|
|
$ |
7,448 |
|
Stock based compensation in connection with IPO
|
|
|
— |
|
|
|
30,886 |
|
|
|
— |
|
Employee stock purchase plan
|
|
|
128 |
|
|
|
— |
|
|
|
— |
|
RSAs – non-employee directors
|
|
|
197 |
|
|
|
20 |
|
|
|
— |
|
RSUs – employees
|
|
|
817 |
|
|
|
88 |
|
|
|
— |
|
RSUs – independent contractors
|
|
|
3,892 |
|
|
|
168 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
5,034 |
|
|
$ |
35,841 |
|
|
$ |
7,448 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Post IPO [Member] |
|
Outstanding Awards Under 2013 Omnibus Equity Incentive Plan |
The following table summarizes the Company’s activity under
the 2013 Plan for the year ended December 31, 2014 (dollars in
thousands, except per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RSA Grants to Non-
employee Directors
|
|
|
RSU Grants to
Employees |
|
|
RSU Grants to
Independent
Contractors |
|
|
Total |
|
|
Weighted-
Average Grant
Date Fair Value
Per Share |
|
Nonvested shares at December 31, 2013
|
|
|
30,000 |
|
|
|
313,155 |
|
|
|
570,760 |
|
|
|
913,915 |
|
|
$ |
14.46 |
|
Granted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
February 2014
|
|
|
—
|
|
|
|
—
|
|
|
|
38,088 |
|
|
|
38,088 |
|
|
|
|
|
May 2014
|
|
|
22,884 |
|
|
|
6,991 |
|
|
|
31,780 |
|
|
|
61,655 |
|
|
|
|
|
August 2014
|
|
|
—
|
|
|
|
6,346 |
|
|
|
12,474 |
|
|
|
18,820 |
|
|
|
|
|
November 2014
|
|
|
—
|
|
|
|
9,584 |
|
|
|
4,638 |
|
|
|
14,222 |
|
|
|
|
|
December 2014
|
|
|
—
|
|
|
|
216,411 |
|
|
|
—
|
|
|
|
216,411 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Granted
|
|
|
22,884 |
|
|
|
239,332 |
|
|
|
86,980 |
|
|
|
349,196 |
|
|
|
27.46 |
|
Vested
|
|
|
(10,002 |
) |
|
|
— |
|
|
|
— |
|
|
|
(10,002 |
) |
|
|
12.00 |
|
Transferred
|
|
|
— |
|
|
|
(8,596 |
) |
|
|
8,596 |
|
|
|
— |
|
|
|
14.54 |
|
Forfeited/canceled
|
|
|
— |
|
|
|
(27,454 |
) |
|
|
(18,646 |
) |
|
|
(46,100 |
) |
|
|
14.65 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonvested shares at December 31, 2014 (1)
|
|
|
42,882 |
|
|
|
516,437 |
|
|
|
647,690 |
|
|
|
1,207,009 |
|
|
$ |
18.23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrecognized stock-based compensation expense as of
December 31, 2014 (2)
|
|
$ |
503 |
|
|
$ |
10,126 |
|
|
$ |
16,546 |
|
|
$ |
27,175 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average remaining vesting period (years) as of
December 31, 2014
|
|
|
2.11 |
|
|
|
4.46 |
|
|
|
4.05 |
|
|
|
4.15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Nonvested RSU’s will be settled
through the issuance of new shares of common stock. |
(2) |
The total unrecognized compensation
expense is expected to be recognized over a weighted-average period
of approximately 4.15 years. |
|